Charles River Laboratories International Inc. (CRL): Price and Financial Metrics

Charles River Laboratories International Inc. (CRL): $194.94

0.50 (+0.26%)

POWR Rating

Component Grades








CRL Price/Volume Stats

Current price $194.94 52-week high $262.00
Prev. close $194.44 52-week low $181.22
Day low $191.10 Volume 403,600
Day high $195.27 Avg. volume 524,247
50-day MA $205.15 Dividend yield N/A
200-day MA $210.81 Market Cap 9.99B

CRL Stock Price Chart Interactive Chart >


  • CRL scores best on the Value dimension, with a Value rank ahead of 68.7% of US stocks.
  • The strongest trend for CRL is in Growth, which has been heading down over the past 177 days.
  • CRL's current lowest rank is in the Momentum metric (where it is better than 7.67% of US stocks).

CRL Stock Summary

  • CRL has a market capitalization of $10,234,788,284 -- more than approximately 84.5% of US stocks.
  • For CRL, its debt to operating expenses ratio is greater than that reported by 75.41% of US equities we're observing.
  • The volatility of CHARLES RIVER LABORATORIES INTERNATIONAL INC's share price is greater than that of 26.64% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to CRL, based on their financial statements, market capitalization, and price volatility, are EDR, LEA, SDPI, HLIO, and ENV.
  • CRL's SEC filings can be seen here. And to visit CHARLES RIVER LABORATORIES INTERNATIONAL INC's official web site, go to

CRL Valuation Summary

  • CRL's price/sales ratio is 2.4; this is 26.32% higher than that of the median Healthcare stock.
  • CRL's price/earnings ratio has moved up 2.9 over the prior 243 months.

Below are key valuation metrics over time for CRL.

Stock Date P/S P/B P/E EV/EBIT
CRL 2023-09-22 2.4 3.1 21.1 17.8
CRL 2023-09-21 2.4 3.1 21.0 17.7
CRL 2023-09-20 2.6 3.3 22.1 18.4
CRL 2023-09-19 2.6 3.3 22.1 18.4
CRL 2023-09-18 2.6 3.3 22.3 18.6
CRL 2023-09-15 2.6 3.3 22.0 18.4

CRL Growth Metrics

    The year over year revenue growth rate now stands at 19.34%.
  • The 4 year cash and equivalents growth rate now stands at 183.17%.
  • The 3 year price growth rate now stands at 91.8%.
CRL's revenue has moved up $1,252,344,000 over the prior 34 months.

The table below shows CRL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 3,976.06 619.64 486.226
2022-09-30 3,781.267 614.141 436.394
2022-06-30 3,688.047 656.084 443.347
2022-03-31 3,629.523 693.2 422.474
2021-12-31 3,540.16 760.799 390.982
2021-09-30 3,426.1 669.92 396.595

CRL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CRL has a Quality Grade of C, ranking ahead of 58.62% of graded US stocks.
  • CRL's asset turnover comes in at 0.564 -- ranking 280th of 561 Business Services stocks.
  • CRTO, OOMA, and SCWX are the stocks whose asset turnover ratios are most correlated with CRL.

The table below shows CRL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-26 0.564 0.379 0.141
2021-03-27 0.559 0.371 0.139
2020-12-26 0.553 0.367 0.135
2020-09-26 0.555 0.367 0.119
2020-06-27 0.558 0.361 0.101
2020-03-28 0.570 0.367 0.096

CRL Price Target

For more insight on analysts targets of CRL, see our CRL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $448.00 Average Broker Recommendation 1.35 (Strong Buy)

Charles River Laboratories International Inc. (CRL) Company Bio

Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratorygene therapy and cell therapy services for the PharmaceuticalMedical device and Biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry (for example, contract research organization services) and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing. (Source:Wikipedia)

CRL Latest News Stream

Event/Time News Detail
Loading, please wait...

CRL Latest Social Stream

Loading social stream, please wait...

View Full CRL Social Stream

Latest CRL News From Around the Web

Below are the latest news stories about CHARLES RIVER LABORATORIES INTERNATIONAL INC that investors may wish to consider to help them evaluate CRL as an investment opportunity.

Unveiling Charles River Laboratories International's Value: Is It Really Priced Right? A ...

Deciphering the intrinsic value of Charles River Laboratories International (CRL) based on its financial strength, profitability, and future growth prospects

Yahoo | September 25, 2023

Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster

STEVENAGE, United Kingdom, September 25, 2023--Charles River opens purpose-built lab offering GMP QC test capabilities to Stevenage biocluster.

Yahoo | September 25, 2023

Unveiling Charles River Laboratories International (CRL)'s Value: Is It Really Priced Right? A ...

Charles River Laboratories International Inc (NYSE:CRL) recently experienced a daily loss of -5.21%, and a 3-month loss of -0.43%. This article aims to answer that question through a detailed valuation analysis of Charles River Laboratories International (NYSE:CRL). Established in 1947, Charles River Laboratories International Inc (NYSE:CRL) is a leading provider of drug discovery and development services.

Yahoo | September 21, 2023

Charles River Laboratories to Host Virtual Investor Day

WILMINGTON, Mass., September 20, 2023--Charles River Laboratories to Host Investor Day on September 21, 2023

Yahoo | September 20, 2023

Unpacking the Investment Potential of Charles River Laboratories International Inc (CRL): A ...

Exploring the robust financial stance and growth prospects of Charles River Laboratories International Inc (CRL)

Yahoo | September 18, 2023

Read More 'CRL' Stories Here

CRL Price Returns

1-mo -4.39%
3-mo -7.28%
6-mo -3.41%
1-year 4.01%
3-year -12.75%
5-year 44.89%
YTD -10.54%
2022 -42.17%
2021 50.80%
2020 63.56%
2019 34.97%
2018 3.41%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!